학술논문
O-005 - Treating HER2-mutant advanced biliary tract cancer with neratinib: benefits of HER2-directed targeted therapy in the phase 2 SUMMIT 'basket' trial.
Document Type
Article
Author
Source
Subject
*BASKETS
BILIARY tract cancer
Language
ISSN
0923-7534